Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II) (SHIELD II)
ClinicalTrials.gov NCT02468778
Research payments
$1,585
Through program year 2019, $1,585 in research payments was reported against Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II) (SHIELD II), across 31 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT02468778
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $1,585 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Joaquin Martinez Arraras Amarillo, TX Named on 2 payments
- Joshua Krasnow Huntsville, AL Named on 2 payments
- Douglas Spriggs Clearwater, FL Named on 2 payments
- Jason Moreland Morgantown, WV Named on 2 payments
- Mudassar Ahmed Saint Paul, MN Named on 2 payments
- Barry Bertolet Tupelo, MS Named on 2 payments
- Amar Patel Marietta, GA Named on 2 payments
- Samin Sharma New York, NY Named on 2 payments
- Jon George Philadelphia, PA Named on 2 payments
- German Larrain Wausau, WI Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.